Vinpocetine is a potent blocker of rat NaV1.8 tetrodotoxin-resistant sodium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 2, 2003, Pages 498-504

  Zhou, Xiaoping ^a   Dong, Xiao Wei ^a   Crona, James ^a   Maguire, Maureen ^a   Priestley, Tony ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; TETRODOTOXIN; VINCAMINE; VINPOCETINE;

ANIMAL CELL; ARTICLE; CELL STRAIN; CELL TYPE; CLONING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DEPOLARIZATION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; ELECTRIC POTENTIAL; HYPERPOLARIZATION; IC 50; MOLECULAR BIOLOGY; NERVE CONDUCTION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSORY NERVE; SODIUM CHANNEL NAV 1.8; SPINAL GANGLION; VOLTAGE CLAMP;

ANIMALS; CELLS, CULTURED; DRUG RESISTANCE; ELECTROPHYSIOLOGY; PATCH-CLAMP TECHNIQUES; RATS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TETRODOTOXIN; VINCA ALKALOIDS;

EID: 0037960990     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.051086     Document Type: Article

References (31)

1. Akopian AN, Sivilotti L, and Wood JN (1996) A tetrodotoxin-resistant voltage-gated sodium channel expressed by sensory neurons. Nature (Lond) 379:257-262.
2. Anonymous (2002) Vinpocetine. Monograph. Altern Med Rev 7:240-243.
3. Balser JR, Nuss HB, Romashko DN, Marban E, and Tomaselli GF (1996) Functional consequences of lidocaine binding to slow-inactivated sodium channels. J Gen Physiol 107:643-658.
4. Bonoczk P, Gulyas B, Adam-Vizi V, Nemes A, Karpati E, Kiss B, Kapas M, Szantay C, Koncz I, Zelles T, et al. (2000) Role of sodium channel inhibition in neuroprotection: effect of vinpocetine. Brain Res Bull 53:245-254.
5. Bonoczk P, Panczel G, and Nagy Z (2002) Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study. Eur J Ultrasound 15:85-91.
6. Catterall WA (1999) Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adu Neurol 79:441-456.
7. Chiu PJ, Tetzloff G, Ahn HS, and Sybertz EJ (1988) Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta. Am J Hypertens 1:262-268.
8. Devor M (2001) Neuropathic pain: what do we do with all these theories? Acta Anaesthesiol Scand 45:1121-1127.
9. Dickenson AH, Matthews EA, and Suzuki R (2002) Neurobiology of neuropathic pain: mode of action of anticonvulsants. Eur J Pain 6:51-60.
10. Dong X-W, Zhou X, Maguire M, Crona J, Smith E, Monsma F, and Priestley T (2001) Characterization of rat PN3 sodium channels expressed in DRG-derived ND7/23 cell line, in Society for Neuroscience Abstracts, p 46.42, San Diego, CA.
11. Elliott AA and Elliott JR (1993) Characterization of TTX-sensitive and TTX-resistant sodium currents in small cells from adult rat dorsal root ganglia. J Physiol (Lond) 463:39-56.
12. Gold MS, Weinreich D, Kim CS, Wang R, Treanor J, Porreca F, and Lai J (2003) Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain. J Neurosci 23:158-166.
13. Goldin (2000) Nomenclature of voltage-gated sodium channels. Neuron 28:365-368.
14. 11C]vinpocetine: a preliminary PET study in a cynomolgus monkey. J Neuroimaging 9:217-222.
15. 11C]ethanol in cynomolgous monkeys: a comparative preclinical PET study. Nucl Med Biol 29:753.
16. Hille B (1992) Mechanisms of Block, in Ionic Channels of Excitable Membranes, pp 390-422, Sinauer Associates, Inc., Sunderland, MA.
17. Horvath B, Marton Z, Halmosi R, Alexy T, Szapary L, Vekasi J, Biro Z, Habon T, Kesmarky G, and Toth K (2002) In vitro antioxidant properties of pentoxifylline, piracetam and vinpocetine. Clin Neuropharmacol 25:37-42.
18. Hunter JC and Loughhead D (1999) Voltage-gated sodium channel blockers for the treatment of chronic pain. Curr Opin CNPS Investig Drugs 1:72-81.
19. Lai J, Gold MS, Kim CS, Bian D, Ossipov MH, Hunter JC, and Porreca F (2002) Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8. Pain 95:143-152.
20. Lai J, Hunter JC, Ossipov MH, and Porreca F (2000) Blockade of neuropathic pain by antisense targeting of tetrodotoxin-resistant sodium channels in sensory neurons. Methods Enzymol, 201-213.
21. Lohmann A, Dingler E, Sommer W, Schaffler K, Wober W, and Schmidt W (1992) Bioavailability of vinpocetine and interference of the time of application with food intake. Arzneimittelforschung 42:914-917.
22. + channels in rat cortical neurons. Eur J Pharmacol 273:303-306.
23. Novakovic SD, Tzoumaka E, McGivern JG, Haraguchi M, Sangameswaran L, Gogas KR, Eglen RM, and Hunter JC (1998) Distribution of the tetrodotoxin-resistant sodium channel PN3 in rat sensory neurons in normal and neuropathic conditions. J Neurosci 18:2174-2187.
24. Rush AM, Brau ME, Elliott AA, and Elliott JR (1998) Electrophysiological properties of sodium current subtypes in small cells from adult rat dorsal root ganglia. J Physiol (Lond) 511:771-789.
25. Sangameswaran L, Delgado SG, Fish LM, Koch BD, Jakeman LB, Stewart GR, Sze P, Hunter JC, Eglen RM, and Herman RC (1996) Structure and function of a novel voltage-gated, tetrodotoxin-resistant sodium channel specific to sensory neurons. J Biol Chem 271:5953-5956.
26. Schmidt J (1990) Comparative studies on the anticonvulsant effectiveness of nootropic drugs in kindled rats. Biomed Biochim Acta 49:413-419.
27. 2+] rise in synaptosomes. Neuroreport 9:1849-1853.
28. Vereczkey L, Czira G, Tamas J, Szentirmay Z, Botar Z, and Szporny L (1979) Pharmacokinetics of vinpocetine in humans. Arzneimittelforschung 29:957-960.
29. Wei Y, Shi NC, Zhong CS, Zheng P, and Liang ZJ (1997) Inhibitory effects of vinpocetine on sodium current in rat cardiomyocytes. Zhongguo Yao Li Xue Bao 18:411-415.
30. Wood JN, Bevan SJ, Coote PR, Dunn PM, Harmar A, Hogan P, Latchman DS, Morrison C, Rougon G, Theveniau M, et al. (1990) Novel cell lines display properties of nociceptive sensory neurons. Proc R Soc Lond B Biol Sci 241:187-194.
31. Yoshimura N, Seki S, Chancellor MB, de Groat WC, and Ueda T (2002) Targeting afferent hyperexcitability for therapy of the painful bladder syndrome. Urology 59:61-67.